| A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma S Yokoyama, SL Woods, GM Boyle, LG Aoude, S MacGregor, V Zismann, ... Nature 480 (7375), 99-103, 2011 | 555 | 2011 |
| Head and neck cancer: past, present and future D Chin, GM Boyle, S Porceddu, DR Theile, PG Parsons, WB Coman Expert review of anticancer therapy 6 (7), 1111-1118, 2006 | 323 | 2006 |
| Antitumor activity of 3-ingenyl angelate: plasma membrane and mitochondrial disruption and necrotic cell death SM Ogbourne, A Suhrbier, B Jones, SJ Cozzi, GM Boyle, M Morris, ... Cancer Research 64 (8), 2833-2839, 2004 | 313 | 2004 |
| What is transforming growth factor-beta (TGF-β)? D Chin, GM Boyle, PG Parsons, WB Coman British journal of plastic surgery 57 (3), 215-221, 2004 | 246 | 2004 |
| Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1/2 trial GA Kennedy, A Varelias, S Vuckovic, L Le Texier, KH Gartlan, P Zhang, ... The Lancet Oncology 15 (13), 1451-1459, 2014 | 237 | 2014 |
| Characterization of the melanoma miRNAome by deep sequencing MS Stark, S Tyagi, DJ Nancarrow, GM Boyle, AL Cook, DC Whiteman, ... PloS one 5 (3), e9685, 2010 | 235 | 2010 |
| Novel markers for poor prognosis in head and neck cancer D Chin, GM Boyle, RM Williams, K Ferguson, N Pandeya, J Pedley, ... International journal of cancer 113 (5), 789-797, 2005 | 210 | 2005 |
| Microarray expression profiling in melanoma reveals a BRAF mutation signature S Pavey, P Johansson, L Packer, J Taylor, M Stark, PM Pollock, ... Oncogene 23 (23), 4060-4067, 2004 | 209 | 2004 |
| Melanoma cell invasiveness is regulated by miR‐211 suppression of the BRN2 transcription factor GM Boyle, SL Woods, VF Bonazzi, MS Stark, E Hacker, LG Aoude, ... Pigment cell & melanoma research 24 (3), 525-537, 2011 | 207 | 2011 |
| Multimodal Polymer Nanoparticles with Combined 19F Magnetic Resonance and Optical Detection for Tunable, Targeted, Multimodal Imaging in Vivo BE Rolfe, I Blakey, O Squires, H Peng, NRB Boase, C Alexander, ... Journal of the American Chemical Society 136 (6), 2413-2419, 2014 | 203 | 2014 |
| Autologous T-cell therapy for cytomegalovirus as a consolidative treatment for recurrent glioblastoma A Schuessler, C Smith, L Beagley, GM Boyle, S Rehan, K Matthews, ... Cancer research 74 (13), 3466-3476, 2014 | 199 | 2014 |
| NFIA controls telencephalic progenitor cell differentiation through repression of the Notch effector Hes1 M Piper, G Barry, J Hawkins, S Mason, C Lindwall, E Little, A Sarkar, ... Journal of Neuroscience 30 (27), 9127-9139, 2010 | 154 | 2010 |
| Potent antimalarial activity of histone deacetylase inhibitor analogues KT Andrews, TN Tran, AJ Lucke, P Kahnberg, GT Le, GM Boyle, ... Antimicrobial agents and chemotherapy 52 (4), 1454-1461, 2008 | 153 | 2008 |
| Validating Eaton's hypothesis: Cubane as a benzene bioisostere BA Chalmers, H Xing, S Houston, C Clark, S Ghassabian, A Kuo, B Cao, ... Angewandte Chemie International Edition 55 (11), 3580-3585, 2016 | 152 | 2016 |
| The oligomycin axis of mitochondrial ATP synthase: OSCP and the proton channel RJ Devenish, M Prescott, GM Boyle, P Nagley Journal of bioenergetics and biomembranes 32, 507-515, 2000 | 134 | 2000 |
| Macrophage inhibitory cytokine-1 is overexpressed in malignant melanoma and is associated with tumorigenicity GM Boyle, J Pedley, AC Martyn, KJ Banducci, GM Strutton, DA Brown, ... Journal of investigative dermatology 129 (2), 383-391, 2009 | 131 | 2009 |
| Nuclear targeting of the growth hormone receptor results in dysregulation of cell proliferation and tumorigenesis BL Conway-Campbell, JW Wooh, AJ Brooks, D Gordon, RJ Brown, ... Proceedings of the National Academy of Sciences 104 (33), 13331-13336, 2007 | 126 | 2007 |
| Type I interferons suppress CD4+ T‐cell‐dependent parasite control during blood‐stage Plasmodium infection A Haque, SE Best, A Ammerdorffer, L Desbarrieres, MM de Oca, ... European journal of immunology 41 (9), 2688-2698, 2011 | 124 | 2011 |
| Over-expression of Eph and ephrin genes in advanced ovarian cancer: ephrin gene expression correlates with shortened survival NI Herath, MD Spanevello, S Sabesan, T Newton, M Cummings, S Duffy, ... BMC cancer 6, 1-7, 2006 | 124 | 2006 |
| Tc17 cells are a proinflammatory, plastic lineage of pathogenic CD8+ T cells that induce GVHD without antileukemic effects KH Gartlan, KA Markey, A Varelias, MD Bunting, M Koyama, RD Kuns, ... Blood, The Journal of the American Society of Hematology 126 (13), 1609-1620, 2015 | 117 | 2015 |
